Biotech · Private company · San Francisco, CA, US
Weatherwax Biotechnologies Corporation
Track this companyFree. Adds Weatherwax Biotechnologies Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of Heterobivalent Small-Molecule Therapeutics for the Treatment of Triple-Negative Breast CancerFiscal year 2025 · $103.7KNIH RePORTER 5R43CA287494-02 · fetched Nov 12, 2026
- Development of Heterobivalent Small-Molecule Therapeutics for the Treatment of Triple-Negative Breast CancerFiscal year 2024 · $296.3KNIH RePORTER 1R43CA287494-01 · fetched Nov 12, 2026